Balb/c Mouse Bone Marrow Mesenchymal Stem Cells
Introduction
Bone marrow mesenchymal stem cells (BMSCs) are a type of multipotent stem cell residing in the bone marrow stroma. Due to their strong proliferative capacity and immunomodulatory properties, BMSCs are widely applied in tissue engineering, cell therapy, and gene therapy.
As a research hotspot, Balb/c mouse bone marrow mesenchymal stem cells are commonly used in regenerative medicine and tissue engineering, particularly in studies involving bone, cardiovascular, and nervous system disorders.
OriCell™ Balb/c Mouse Bone Marrow Mesenchymal Stem Cells are isolated from the bone marrow of healthy Balb/c mice. These cells exhibit robust proliferation and multipotent differentiation potential, making them a valuable cell model for studying proliferation, aging, immune regulation, differentiation, and transplantation.
When citing our products in academic journals, please indicate "OriCell™ + Catalog Number, from Cyagen Biosciences (Guangzhou) Inc."
Product Information
| Name | OriCell™ Balb/c Mouse Bone Marrow Mesenchymal Stem Cells |
| Catalog Number | MUCMX-01001 |
| Amount of Cells | 1×106 cells/vial |
| Passage Number | P6 |
| Storage at | Liquid Nitrogen (-196℃) |
QC
- Pass the detection of bacteria, fungi, mycoplasma, and endotoxins.
- Pass the viability examination. The viable rates is higher than 80%.
- The cell doubling time is less than 72 hours.
- Flow cytometry showed that CD29, CD44 and Sca-1 are positive (>70%), while CD117 and CD31 are negative (<5%).
- The cells can be induced to differentiate into osteoblasts, adipocytes, chondrocytes, etc.
Please refer to "COA" for details.
General Handing Principles
- Ensure that all equipment is kept clean and tidy.
- Please follow the instructions.
- Use suitable and reliable consumables and reagents.
- Bone marrow mesenchymal stem cells have limited ability to proliferate in vitro and cannot maintain their differentiation potential for a long time. OriCell™ Balb/c Mouse Bone Marrow Mesenchymal Stem Cells can be passaged for more than 5 times and still maintain all indicators qualified. But we always recommend using lower generation cells for scientific research.
- Usually the inoculation density of mouse bone marrow mesenchymal stem cells is (2.5~4) ×104 live cells/cm2.
Warm Notice: The cryopreservation solution of this product contains DMSO, which has potential risks. Please handle it carefully.
- Imaging the survival and utility of pre-differentiated allogeneic MSC in ischemic heart. 点击索取文献 ››
- CCR2 Positive Exosome Released by Mesenchymal Stem Cells Suppresses Macrophage Functions and Alleviates IschemiaReperfusion-Induced Renal Injury. 点击索取文献 ››
- The Optimal Intervention Time of Bone Marrow Mesenchymal Stem Cells in Ameliorating Cardiac Fibrosis Induced by Viral Myocarditis: A Randomized Controlled Trial in Mice. 点击索取文献 ››
- SCAFFOLDS WITH INTEGRATED PROPERTIES AND APPLICATIONS IN CELL TRANSPLANTATION. 点击索取文献 ››
- Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation. 点击索取文献 ››
-
Imaging the survival and utility of pre-differentiated allogeneic MSC in ischemic heart.
Biochem Biophys Res Commun 438:382 (2013) IF = 2.297 Year 2013
-
CCR2 Positive Exosome Released by Mesenchymal Stem Cells Suppresses Macrophage Functions and Alleviates IschemiaReperfusion-Induced Renal Injury.
Stem Cells International 1240301 (2016) IF = 3.687 Year 2016
-
The Optimal Intervention Time of Bone Marrow Mesenchymal Stem Cells in Ameliorating Cardiac Fibrosis Induced by Viral Myocarditis: A Randomized Controlled Trial in Mice.
Stem Cells International -2017 IF = 3.54 Year 2017
-
SCAFFOLDS WITH INTEGRATED PROPERTIES AND APPLICATIONS IN CELL TRANSPLANTATION.
Dissertation -2017 Year 2017
-
Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation.
Scientific Reports PMID: 32165680 (2020) IF = 4.011 Year 2020